Article
Linc RNA ‐p21 suppresses development of human prostate cancer through inhibition of PKM 2
9 Oct 2017
Abstract excerpt
OBJECTIVES: Previously, we found that long intergenic non-coding RNA-p21 (lincRNA-p21) inhibited the development of human prostate cancer. However, the underlying molecular mechanisms are poorly understood. Here, we attempted to investigate the downstream targets of lincRNA-p21 in prostate cancer. MATERIALS AND METHODS: Expression of lincRNA-p21 and PKM2 was determined by qRT-PCR and Western blot. Lentivirus...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
